COLA MICHAEL F (President and CEO) purchased 132.0% of their position (100K shares) of AEVI GENOMIC MEDICINE, LLC on the open market
Open‑market purchase worth $250.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/11/2020ACC: 0001192482-20-000475
DirectorOfficer· President and CEO
Since Dec 2019
+100K
Net shares
Net buyer
$250.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$2.50
Trade value
$250K
% of position
132.0%
6/9/2020
75.75K→175.75K
Total
Net shares
+100K
Net value
$250K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2020 | P · Purchase | +100K | $2.50 | $250K | 132.0% | 75.75K | 175.75K |
| Total | +100K | $250K | ||||||
Derivative Transactions0
No derivative transactions reported